Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone replacement in young male cancer survivors with borderline low testosterone
2011-000677-31Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of AndroForte in Hypoandrogenism (TD), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoints: Truncal fat mass at 26 weeks and SF-36 physical functioning scale at 26 weeks. Started Aug 2011; status: completed.
02
Drugs
AndroForte
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2011-000677-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000677-31.